LANRAPLENIB

Search structure


Synonyms:	GS-SYK
Status:	Phase 2
Entry Type:	Small molecule
Molecule Category:	UNKNOWN
UNII:	A6U64OU57E

Structure


InChI Key	XCIGZBVOUQVIPI-UHFFFAOYSA-N
Smile	Nc1cncc(-c2cn3ccnc3c(Nc3ccc(N4CCN(C5COC5)CC4)cc3)n2)n1
InChI	InChI=1S/C23H25N9O/c24-21-12-25-11-19(28-21)20-13-32-6-5-26-23(32)22(29-20)27-16-1-3-17(4-2-16)30-7-9-31(10-8-30)18-14-33-15-18/h1-6,11-13,18H,7-10,14-15H2,(H2,24,28)(H,27,29)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C23H25N9O
Molecular Weight	443.52
AlogP	2.03
Hydrogen Bond Acceptor	10.0
Hydrogen Bond Donor	2.0
Number of Rotational Bond	5.0
Polar Surface Area	109.73
Molecular species	NEUTRAL
Aromatic Rings	4.0
Heavy Atoms	33.0

Pharmacology

Action	Mechanism of Action	Reference
INHIBITOR	Tyrosine-protein kinase SYK inhibitor

Targets	EC50(nM)	IC50(nM)	Kd(nM)	Ki(nM)	Inhibition(%)
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase JakA family	-	120	-	-	-
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase JakB family	-	120	-	-	-
Enzyme Kinase Protein Kinase TK protein kinase group Tyrosine protein kinase Syk family	24-1305	6.2-13.5	-	-	-
Surface antigen	-	80	-	-	-

Indications

Mesh Heading	Maximum Phase	Mesh ID	Reference
Sjogren's Syndrome	2	D012859	ClinicalTrials
Lupus Erythematosus, Cutaneous	2	D008178	ClinicalTrials
Lupus Erythematosus, Systemic	2	D008180	ClinicalTrials
Leukemia, Myeloid, Acute	1	D015470	ClinicalTrials

Cross References

Resources	Reference
CAS NUMBER	1800046-95-0
ChEMBL	CHEMBL3986824
DrugBank	DB14770
FDA SRS	A6U64OU57E
Guide to Pharmacology	9764
PDB	R6D
PubChem	118161062
SureChEMBL	SCHEMBL16820581

CONTENTS